Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001575705-21-000531
Filing Date
2021-08-16
Accepted
2021-08-16 13:58:36
Documents
68
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10q.htm   iXBRL 10-Q 711028
2 EX-31 ex311.htm EX-31 15302
3 EX-32 ex321.htm EX-32 6762
  Complete submission text file 0001575705-21-000531.txt   4079654

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE qron-20210630.xsd EX-101.SCH 40508
5 XBRL CALCULATION FILE qron-20210630_cal.xml EX-101.CAL 41346
6 XBRL DEFINITION FILE qron-20210630_def.xml EX-101.DEF 127070
7 XBRL LABEL FILE qron-20210630_lab.xml EX-101.LAB 242622
8 XBRL PRESENTATION FILE qron-20210630_pre.xml EX-101.PRE 239923
9 EXTRACTED XBRL INSTANCE DOCUMENT form10q_htm.xml XML 665597
Mailing Address 50 BATTERY PLACE, #7T NEW YORK NY 10280
Business Address 50 BATTERY PLACE, #7T NEW YORK NY 10280 212-945-2080
Qrons Inc. (Filer) CIK: 0001689084 (see all company filings)

EIN.: 813623646 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55800 | Film No.: 211176633
SIC: 2836 Biological Products, (No Diagnostic Substances)